OPRD1

OPRD1

Target · GPCR, opioid receptor

OPRD1 Delta-type opioid receptor · opioid receptor, delta 1

OPRD1 (opioid receptor delta 1) is a G protein-coupled receptor for endogenous enkephalins and a subset of other opioids. It signals through G proteins to inhibit adenylate cyclase and plays a role in pain perception and opiate-mediated analgesia. Browse Assay Genie's current range of OPRD1 research reagents below, or read on for the biology behind the target.

Cell membrane receptorEnkephalin GPCRRole in morphine tolerance
372 aa
Protein length
~40 kDa
Molecular weight
1p35.3
Gene locus
GPCR family 1
Receptor class
Target information

What is OPRD1 (opioid receptor delta 1)?

OPRD1, the delta-type opioid receptor, is a G protein-coupled receptor that binds endogenous enkephalins and a subset of other opioids. Ligand binding causes a conformational change that triggers signalling via guanine nucleotide-binding proteins (G proteins) and modulates down-stream effectors such as adenylate cyclase. The net result of this signalling is inhibition of adenylate cyclase activity. OPRD1 also inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance.

The receptor is located in the plasma membrane and belongs to the G protein-coupled receptor 1 family. HGNC places the OPRD1 gene in the opioid receptors group, and the previous name for the gene was opioid receptor, delta 1. Mouse and rat both carry an ortholog named Oprd1, which allows the receptor to be studied in common rodent models.

Functionally, OPRD1 plays a role in the perception of pain and in opiate-mediated analgesia, and it contributes to the development of analgesic tolerance to morphine. NCBI Gene also links it to the G protein-coupled opioid receptor signalling pathway, the cellular response to hypoxia and the regulation of mitochondrial membrane potential. The gene has been implicated in alcohol dependence, alcohol use disorder, drug dependence and withdrawal disorder, and is described as a biomarker of opioid abuse.

Pain and analgesia

OPRD1 plays a role in pain perception and opiate-mediated analgesia, making it a central receptor in studies of nociception.

Opioid tolerance

The receptor contributes to the development of analgesic tolerance to morphine, a focus for work on opioid response over time.

Addiction and dependence

OPRD1 is implicated in alcohol use disorder, drug dependence and withdrawal, and is described as a biomarker of opioid abuse.

GPCR signalling and neurotransmission

Coupling to G proteins inhibits adenylate cyclase and modulates calcium and potassium currents, so OPRD1 is used to examine neurotransmitter release control.

Background

OPRD1 frequently asked questions

What does OPRD1 do?

OPRD1 is a G protein-coupled receptor for enkephalins and some other opioids. Ligand binding triggers G protein signalling that inhibits adenylate cyclase, reduces calcium currents and increases potassium conductance, which suppresses neurotransmitter release. It contributes to pain perception, opiate analgesia and morphine tolerance.

What other names does OPRD1 go by?

The UniProt protein name is delta-type opioid receptor, and the HGNC full name is opioid receptor delta 1. The previous gene name was opioid receptor, delta 1. No alternative gene symbols are listed. It is classified within the HGNC opioid receptors gene group.

Is OPRD1 conserved across species and linked to disease?

Mouse and rat each have an ortholog called Oprd1, so rodent models are widely applicable; check the datasheet of any product for its validated reactivity. In humans, OPRD1 is implicated in alcohol dependence, alcohol use disorder, drug dependence, opioid abuse and withdrawal disorder.

Explore

Related targets

Other opioid receptors, enkephalin precursors and G protein signalling partners with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P41143; product specifications from Assay Genie datasheets.

OPRD1 Product listing